Transfer of the ADA Gene into Bone Marrow Cells and Peripheral Blood Lymphocytes for the Treatment of Patients Affected by ADA-Deficient SCID-Reference-Cited by-同舟云学术

Transfer of the ADA Gene into Bone Marrow Cells and Peripheral Blood Lymphocytes for the Treatment of Patients Affected by ADA-Deficient SCID

Published:1993-08 Issue:4 Volume:4 Page:513-520
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Bordignon Claudio¹,Mavilio Fulvio²,Ferrari Giuliana²,Servida Paolo²,Ugazio Alberto G.³,Notarangelo Luigi D.³,Gilboa Eli⁴,Rossini Silvano²,O'Reilly Richard J.⁴,Smith Clayton A.⁴,Gillio Alfred P.⁴,Anderson W. French⁵,Blaese R. Michael⁶,Moen Robert C.⁷,Eglitis Martin A.⁷

Affiliation:

1. Head, Bone Marrow Transplantation and Gene Therapy Program, Istituto Scientifico H.S. Raffaele, via Olgettina 60, 20132 Milano, Italy. Telephone: 39-2-26432357; Telefax: 39-2-26432285.

2. Istituto Scientifico H.S. Raffaele.

3. Clinica Pediatrica, Università di Brescia.

4. Memorial Sloan-Kettering Cancer Center.

5. Chief, Molecular Hematology Branch, NHLBI.

6. Chief, Cellular Immunology Section, Metabolism Branch, NCI.

7. Genetic Therapy Inc.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.1993.4.4-513